Tolmar Pharmaceuticals, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
  • Digital Health
    • Disease Management

Other Names/Subsidiaries

  • TOLMAR Inc
  • TOLMAR Therapeutics
  • TOLMAR Pharmaceuticals
See more in Biomedtracker

Latest on Tolmar Pharmaceuticals, Inc.

Pink Sheet

Testosterone, TRAVERSE, And A Label Change 15 Years In The Making

 
• By Bridget Silverman

The US Food and Drug Administration’s newly revised stand on testosterone labeling for cardiovascular risk is the visible tip of the metaphorical iceberg of years of effort that went into evaluating a

Scrip

Deal Watch: OrsoBio Reveals Its Metabolic Health Focus With Four Licensing Pacts

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. OrsoBio Splurges With Four Concurrent L

Scrip

Finance Watch: With Limited Fundraising Options, Biotechs Restructure To Extend Cash Runways

 
• By Mandy Jackson

Bogged down by an ongoing spat with its largest shareholder and a share price that continues to flirt with penny stock territory, Mereo BioPharma Group plc announced an updated operating plan on 18

Scrip

Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis